Kiran Musunuru

27PUBLICATIONS
78CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 15, 2026
Efficient prime editing in vivo and in vitro using lipid nanoparticles.

|Nov 25, 2025
Measurement and clinical interpretation of CRISPR off-targets.

Ariella Angelini Stewart, Rebecca C Ahrens-Nicklas, Shengdar Q Tsai

|Nov 21, 2025
Chimeric Antigen Receptor Regulatory T Cells Targeted Against Oxidized Low-Density Lipoprotein Reduce Atherosclerotic Plaque Development.

Robert D Schwab, David Degaramo, Seok Jae Hong

|Oct 29, 2025
Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAs.

Madelynn N Whittaker, Lauren C Testa, Aidan Quigley

|Jul 15, 2025
Platform solutions for commercial challenges to expanding patient access and making gene editing sustainable.

Sadik H Kassim, Fyodor Urnov, Kiran Musunuru

|Jul 02, 2025
Gene therapy and genome editing for lipoprotein disorders.

Chen Gurevitz, Archna Bajaj, Amit V Khera

Pageof 5

Frequent Collaborators

5 joint publications

Xiao Wang

4 joint publications

David R Liu

3 joint publications

Megan A Allyse

3 joint publications

Kelly E Ormond